ShockWave Medical

Summary

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

History

ShockWave Medical, Inc. was founded in 2013 by an experienced team of medical device entrepreneurs and medical device engineers. The company has achieved a number of milestones that have led to the successful first-in-human and clinical trials of its Intravascular Lithotripsy (IVL) therapy platform.

Vision

ShockWave Medical, Inc. strives to continuously improve and evolve the standards of care for the treatment of calcified and fibrotic lesions in coronary, peripheral and carotid vascular disease.

References

https://in.investing.com/equities/shockwave-medical

https://finance.yahoo.com/quote/SWAV/profile?p=SWAV

https://www.crunchbase.com/organization/shockwave-medical

https://sec.report/CIK/0001642545

https://companiesmarketcap.com/

https://www.shockwavemedical.com

Contacts

Follow Us

Contacts

Follow Us

ShockWave Medical

Share